AOD-9604 works by mimicking the specific fat-metabolizing action of human growth hormone without activating the full HGH receptor cascade
doi: 10.1302/2046-3758.81.BJR-2018-0164.R1
Schlessinger, J., Axelrod, D., Koppel, D
Research in obese rodent models has explored its effects on weight gain and fat oxidation, without the broader hormonal actions of full-length growth hormone
FDA Advisory Panel Votes to Loosen Rules on BPC-157, TB-500, and MOTS-C Despite Agency Scientists' Opposition An FDA advisory committee voted narrowly on July 23, 2026, to recommend that compounding pharmacies gain access to several popular peptide compounds, including BPC-157, KPV, TB-500, and MOTS-C, overriding explicit objections from the FDA's own career scientists and sparking an audible gasp in the meeting room when the tally was announced